(Q44283510)

1 December 2017

title

Cardiovascular effects of Y-27632, a selective Rho-associated kinase inhibitor, assessed in the halothane-anesthetized canine model (English)

1 reference

1 December 2017

1 reference

1 reference

1 December 2017

Atsushi Sugiyama

1 reference

1 December 2017

Yoshioki Satoh

series ordinal

1 reference

1 December 2017

Masahiko Yoneyama

series ordinal

1 reference

1 December 2017

Keitaro Hashimoto

series ordinal

1 reference

1 December 2017

language of work or name

English

0 references

publication date

1 January 2003

1 reference

European Journal of Pharmacology

1 December 2017

published in

1 reference

1 December 2017

volume

460

1 reference

1 December 2017

1 reference

1 December 2017

page(s)

51-57

1 reference

The small GTP-binding protein RhoA regulates a delayed rectifier potassium channel

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902929-1

Bridging the gap between basic and clinical electrophysiology: what can be learned from monophasic action potential recordings?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902929-1

Frequency-dependent effects of quinidine on the relationship between action potential duration and refractoriness in the canine heart in situ

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902929-1

Rho GTPases and the actin cytoskeleton

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902929-1

Cell migration--movin' on.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902929-1

Evaluation of Y-27632, a rho-kinase inhibitor, as a bronchodilator in guinea pigs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902929-1

An essential part for Rho-associated kinase in the transcellular invasion of tumor cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902929-1

Postrepolarization refractoriness versus conduction slowing caused by class I antiarrhythmic drugs: antiarrhythmic and proarrhythmic effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902929-1

Circumferential stretching of saphenous vein smooth muscle enhances vasoconstrictor responses by Rho kinase-dependent pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902929-1

Cardiac-specific overexpression of RhoA results in sinus and atrioventricular nodal dysfunction and contractile failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902929-1

Isoproterenol antagonizes prolongation of refractory period by the class III antiarrhythmic agent E-4031 in guinea pig myocytes. Mechanism of action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902929-1

Effects of a class III antiarrhythmic drug, dofetilide, on the in situ canine heart assessed by the simultaneous monitoring of hemodynamic and electrophysiological parameters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902929-1

Inhibition of rho-associated kinase results in suppression of neointimal formation of balloon-injured arteries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902929-1

Comparison of the electropharmacological effects of verapamil and propranolol in the halothane-anesthetized in vivo canine model under monophasic action potential monitoring.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902929-1

Rho-kinase as a novel therapeutic target in treatment of cardiovascular diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902929-1

Anti-anginal effect of fasudil, a Rho-kinase inhibitor, in patients with stable effort angina: a multicenter study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902929-1

Effects of gastrointestinal prokinetic agents, TKS159 and cisapride, on the in situ canine heart assessed by cardiohemodynamic and electrophysiological monitoring

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902929-1

Effects of a typical I(Kr) channel blocker sematilide on the relationship between ventricular repolarization, refractoriness and onset of torsades de pointes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902929-1

Electrophysiologic, cardiohemodynamic and beta-blocking actions of a new ultra-short-acting beta-blocker, ONO-1101, assessed by the in vivo canine model in comparison with esmolol.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902929-1

Electropharmacologic effects of a new phosphodiesterase III inhibitor, toborinone (OPC-18790), assessed in an in vivo canine model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902929-1

Cardiac electrophysiologic and hemodynamic effects of sildenafil, a PDE5 inhibitor, in anesthetized dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902929-1

In vivo canine model comparison of cardiohemodynamic and electrophysiological effects of a new antipsychotic drug aripiprazole (OPC-14597) to haloperidol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902929-1

Cardiac effects of a selective rho-associated kinase inhibitor, Y-27632, assessed in canine isolated, blood-perfused heart preparations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902929-1

Electrophysiological and cardiohemodynamic effects of AH-1058, a new type calcium channel blocker, assessed by the in vivo canine model.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902929-1

Small GTP-binding proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902929-1

Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902929-1

10.1016/S0014-2999(02)02929-1

7 January 2021

Identifiers

DOI

1 reference

release_igdvyhga6jbmpl2jgrpqwwkqj4

1 December 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/igdvyhga6jbmpl2jgrpqwwkqj4

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference